Effects of Covid-19 on Patients with Cardiovascular Diseases: A Systematic Review
Naveen Sharma *
Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, 474005, India.
Priyanka Joshi
Shri Ram College of Pharmacy, Banmore, National Express Way A.B. Road Banmore, Morena (M.P.), India.
Pawan Kumar Gupta
Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, 474005, India.
Parjanya Kumar Shukla
Krishnarpit Institute of Pharmacy, Prayagraj, Uttar Pradesh-212107, India.
. Archna
Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, 474005, India.
*Author to whom correspondence should be addressed.
Abstract
Aim of Object: During the COVID-19 pandemic, the entire world is experiencing a mortality situation; most people are battling against the corona virus, but some individuals have already suffered from cardiovascular problems.
For improved patient care, adequate information and comprehension of the relationship between cardiovascular disorders and COVID-19 is required. The dominant clinical manifestations of the corona virus infection are on the respiratory system. In this instance, the acute cardiac injury is the most often reported cardiac abnormality, in which the degree of cardiac output is increased, troponin levels rise, and mostly it is found in about 8% to 12% of patients. The involvement of viral cardiomyocytes and systemic inflammation is the most prevalent mechanism for cardiac damage. The corona virus attaches itself and enters through angiotensin converting enzyme-II.
Discussion and Conclusion: Recent articles on COVID-19 have revealed nothing regarding these individuals' cardiac vascular manifestations. This is a critical component of all that has a big influence on COVID-19 patients' cardiovascular systems. To fully comprehend the method and effects, more study is required.
Keywords: COVID-19, cardiovascular disease, cardiac troponins, angiotensin converting enzyme-II (ACE-II)